Skip to content

Kinesiology Taping in breast cancer-related lymphedema

Effect of Kinesiology Taping on breast cancer-related lymphedema: a randomized single blind controlled pilot study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613001173785
Enrollment
75
Registered
2013-10-25
Start date
2012-12-17
Completion date
2013-08-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Kinesiology Taping (KT) for lymphatic drainage is a new choice in the field of physical and alternative therapy. The material used for the Kinesio tape and the original concept of the taping technique was introduced by Dr. Kenso Kase in 1973. K-tape had been designed to allow 30-40% longitudinal stretch. It is composed of 100% cotton fibers and acrylic heat sensitive glue. Development of the technique for its administration is still ongoing. Dr. Kase claimed that applying K-tape would have physiological effects including decreasing pain or abnormal sensation, supporting the movement of muscles, removing congestion of lymphatic fluid or hemorrhages under the skin, and correcting misalignment of joints. After applying K-tape, the taped area will form convolutions to increase the space between the skin and muscles. Once the skin is lifted, the flow of blood and lymphatic fluid is promoted. Other advantages are that a patient can take a shower without taking the tape off since it is waterproof. Patients can wear it 1 to 4 days and even longer if it is applied on the back or buttock area. Many practitioners use it in clinical practice in European countries, and it has a beneficial effect. However, there is insufficient evidence for its clinical effects on lymphedematic limbs. The aim of the study is to assess the efficacy of Kinesiology Taping (KT) for treating breast cancer-related lymphedema. The endpoints are the reduction of limb volume and percentage edema size after a month therapy.

Interventions

The aim of the study is to assess the efficacy of Kinesiology Taping (KT) for treating breast cancer-related lymphedema. The endpoints are the reduction of limb volume and percentage edema size after a month therapy. Intervention: Subjects from all three groups receive a routine treatment, including skin care, 45-min pneumatic compression therapy (at 90 mmHg, 12 chambers), 1-h manual lymphatic drainage, application of a multi-layered short-stretch bandages (50-60 mmHg). The tape groups (KT and

The aim of the study is to assess the efficacy of Kinesiology Taping (KT) for treating breast cancer-related lymphedema. The endpoints are the reduction of limb volume and percentage edema size after a month therapy. Intervention: Subjects from all three groups receive a routine treatment, including skin care, 45-min pneumatic compression therapy (at 90 mmHg, 12 chambers), 1-h manual lymphatic drainage, application of a multi-layered short-stretch bandages (50-60 mmHg). The tape groups (KT and Quasi KT groups also receive standard therapy - only skin care, pneumatic compression and manual drainage - the same as in MCT group), but K or Quasi tapes are used instead of a bandages. Each groups are treated 3 times weekly (bandages or K-tapes are applied and changed on Mondays, Wednesdays and Fridays) for in the 4-week intervention period. One physical therapist (PTs) provides treatment. The program is standardized, following the same protocol for lymphatic drainage to the anterior trunk, posterior trunk and affected arm, always moving fluid from the affected side toward the unimpaired side. After lymphatic drainage and before either the short-stretch bandages or the K-tape are applied by the physical therapist. In KT group the fan tape anchor starts at the anterior aspect of the hand with no tension. The tails of the tape are applied to the anterior, medial and posterior aspects of the forearm and arm with 5 – 15% tension, and then on anterior part of chest. The tapes are left on the patient’s skin for the next three days. In Quasi KT group we use tapes without therapeutic effects (tapes were apllied without any tension) with the same methodology as in KT group (anatomical placement of tapes on upper limb was the same in both groups). In MCT group we use 4-layered compression bandaging. The first layer is applied to the skin directly with Tubula orthopedic sleeve. Then a supporting bandage Matoplast is applied to the fingers and on hand. Another layer is cotton RoltaSoft covering whole limb. The external layer consists of short – stretch Hartmann bandages. Measurements: To assess the volume of limb we use an optoelectronic Perometer 400 T, co - operating with a personal computer. This method allows to estimate the volume of the measuring error for only 0.5%. The assessment technique is based on a special ring, equipped with a system of 378 LED diodes (emitting the infrared radiation). Within the ring are also the optical sensors that receive electromagnetic stimuli. In the course of measuring the limb is located inside the ring on the diode - sensor lines. The registered light pulses on the detectors is turned into electronic signals. The ring moves during measurement to cover the entire limb. Measurements of the limb volume (both affected and healthy upper limb) are made for all three groups of patients before and after therapy

Sponsors

Academy School of Physical Education
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

(1) unilateral breast cancer-related lymphedema for at least one year, (2) moderate to severe lymphedema (stage II and III of upper limb edema, the volume difference between affected and healthy extremity more than 20%), (3) lack of chemo- or radiation therapy for at least 6 months, (4) good compliance and willingness to sign the written consent form.

Exclusion criteria

(1) active cancer or disease that might lead to swelling and presently taking diuretic therapy or other lymphedema-influencing drugs, (2) skin disease, (3) irremovable bracelet or ring, (4) marked restriction of active range of motion in the affected upper extremity, (5) the presence of a pacemaker, heart disease, pregnancy, metallic devices in the limb to be treated, infectious disease, epilepsy, cartilage growth, thrombophlebitis, arterial hypertension or metastases, which are the treatment contraindications, and (6) the presence of mental, sensorial or language problems, which could make cooperation difficult.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 22, 2026